APA-referens

Mikhael, J. R., Schuster, S. R., Jimenez-Zepeda, V. H., Bello, N., Spong, J., Reeder, C. B., . . . Fonseca, R. (2012). Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis. American Society of Hematology.

Chicago-stil citat

Mikhael, Joseph R., Steven R. Schuster, Victor H. Jimenez-Zepeda, Nancy Bello, Jacy Spong, Craig B. Reeder, A. Keith Stewart, P. Leif Bergsagel, och Rafael Fonseca. Cyclophosphamide-bortezomib-dexamethasone (CyBorD) Produces Rapid and Complete Hematologic Response in Patients With AL Amyloidosis. American Society of Hematology, 2012.

MLA-referens

Mikhael, Joseph R., et al. Cyclophosphamide-bortezomib-dexamethasone (CyBorD) Produces Rapid and Complete Hematologic Response in Patients With AL Amyloidosis. American Society of Hematology, 2012.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.